Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation

Author:

Cuesta-Muñoz Antonio L.1,Huopio Hanna2,Otonkoski Timo3,Gomez-Zumaquero Juan M.1,Näntö-Salonen Kirsti4,Rahier Jacques5,López-Enriquez Soledad1,García-Gimeno Maria A.6,Sanz Pascual6,Soriguer Federico C.1,Laakso Markku7

Affiliation:

1. Hospital Carlos Haya Foundation and Department of Endocrinology, Diabetes, and Nutrition of Carlos Haya University Hospital, Málaga, Spain

2. Department of Paediatrics, University of Kuopio, Kuopio, Finland

3. Hospital for Children and Adolescents, Program of Developmental and Reproductive Biology, Biomedicum, University of Helsinki, Helsinki, Finland

4. Department of Paediatrics, University of Turku, Turku, Finland

5. Department d’Anatomie Pathologique, Cliniques Universitaires Sain Luc, Brussels, Belgium

6. Institute of Biomedicine of Valencia (CSIC), Valencia, Spain

7. Department of Medicine, University of Kuopio, Kuopio, Finland

Abstract

Glucokinase (GK) is a glycolytic key enzyme that functions as a glucose sensor in the pancreatic β-cell, where it governs glucose-stimulated insulin secretion (GSIS). Heterozygous inactivating mutations in the glucokinase gene (GCK) cause a mild form of diabetes (maturity-onset diabetes of the young [MODY]2), and activating mutations have been associated with a mild form of familial hyperinsulinemic hypoglycemia. We describe the first case of severe persistent hyperinsulinemic hypoglycemia due to a “de novo” mutation in GCK (Y214C). A baby girl presented with hypoglycemic seizures since the first postnatal day as well as with inappropriate hyperinsulinemia. Severe hypoglycemia persisted even after treatment with diazoxide and subtotal pancreatectomy, leading to irreversible brain damage. Pancreatic histology revealed abnormally large and hyperfunctional islets. The mutation is located in the putative allosteric activator domain of the protein. Functional studies of purified recombinant glutathionyl S-transferase fusion protein of GK-Y214C showed a sixfold increase in its affinity for glucose, a lowered cooperativity, and increased kcat. The relative activity index of GK-Y214C was 130, and the threshold for GSIS predicted by mathematical modeling was 0.8 mmol/l, compared with 5 mmol/l in the wild-type enzyme. In conclusion, we have identified a de novo GCK activating mutation that causes hyperinsulinemic hypoglycemia of exceptional severity. These findings demonstrate that the range of the clinical phenotype caused by GCK mutations varies from complete insulin deficiency to extreme hyperinsulinemia.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 174 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3